Themis Medicare Limited (NSE:THEMISMED)
India · Delayed Price · Currency is INR 101.75
+3.11 (3.15%)
May 22, 2026, 3:30 PM IST
Themis Medicare Market Cap
Themis Medicare has a market cap or net worth of 9.27 billion as of May 22, 2026. Its market cap has decreased by -23.51% in one year.
Market Cap
9.27B
Enterprise Value
10.10B
Revenue
3.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
101.75
Market Cap Chart
Since July 26, 2001, Themis Medicare's market cap has increased from 94.35M to 9.27B, an increase of 9,722.82%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 9.27B | -0.02% |
| Dec 31, 2025 | 9.27B | -61.73% |
| Dec 31, 2024 | 24.22B | 23.62% |
| Dec 29, 2023 | 19.59B | 58.02% |
| Dec 30, 2022 | 12.40B | 42.22% |
| Dec 31, 2021 | 8.72B | 162.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 35.83B |
| Solara Active Pharma Sciences | 26.40B |
| Indoco Remedies | 18.38B |
| Sakar Healthcare | 16.95B |
| Windlas Biotech | 16.67B |
| Jagsonpal Pharmaceuticals | 14.09B |
| Beta Drugs | 13.90B |
| Ind-Swift Laboratories | 11.43B |